全文获取类型
收费全文 | 35160篇 |
免费 | 2341篇 |
国内免费 | 106篇 |
专业分类
耳鼻咽喉 | 503篇 |
儿科学 | 877篇 |
妇产科学 | 523篇 |
基础医学 | 4364篇 |
口腔科学 | 490篇 |
临床医学 | 3834篇 |
内科学 | 7099篇 |
皮肤病学 | 453篇 |
神经病学 | 3054篇 |
特种医学 | 1411篇 |
外科学 | 5935篇 |
综合类 | 397篇 |
一般理论 | 40篇 |
预防医学 | 3080篇 |
眼科学 | 525篇 |
药学 | 2668篇 |
中国医学 | 32篇 |
肿瘤学 | 2322篇 |
出版年
2023年 | 229篇 |
2022年 | 186篇 |
2021年 | 1013篇 |
2020年 | 652篇 |
2019年 | 997篇 |
2018年 | 1193篇 |
2017年 | 839篇 |
2016年 | 854篇 |
2015年 | 1020篇 |
2014年 | 1510篇 |
2013年 | 2002篇 |
2012年 | 2900篇 |
2011年 | 2945篇 |
2010年 | 1562篇 |
2009年 | 1451篇 |
2008年 | 2497篇 |
2007年 | 2440篇 |
2006年 | 2274篇 |
2005年 | 2287篇 |
2004年 | 2158篇 |
2003年 | 1908篇 |
2002年 | 1782篇 |
2001年 | 199篇 |
2000年 | 169篇 |
1999年 | 214篇 |
1998年 | 284篇 |
1997年 | 203篇 |
1996年 | 207篇 |
1995年 | 169篇 |
1994年 | 179篇 |
1993年 | 147篇 |
1992年 | 86篇 |
1991年 | 87篇 |
1990年 | 75篇 |
1989年 | 70篇 |
1988年 | 55篇 |
1987年 | 53篇 |
1986年 | 37篇 |
1985年 | 45篇 |
1984年 | 61篇 |
1983年 | 62篇 |
1982年 | 74篇 |
1981年 | 51篇 |
1980年 | 42篇 |
1979年 | 24篇 |
1978年 | 22篇 |
1977年 | 20篇 |
1976年 | 13篇 |
1975年 | 16篇 |
1928年 | 12篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
1.
2.
3.
Kevin Kyung Ho Choi Santosh Sanagapalli 《World journal of gastrointestinal oncology》2022,14(3):568-586
Barrett's esophagus (BE) is the precursor to esophageal adenocarcinoma (EAC). Progression to cancer typically occurs in a stepwise fashion through worsening dysplasia and ultimately, invasive neoplasia. Established EAC with deep involvement of the esophageal wall and/or metastatic disease is invariably associated with poor long-term survival rates. This guides the rationale of surveillance of Barrett’s in an attempt to treat lesions at an earlier, and potentially curative stage. The last two decades have seen a paradigm shift in management of Barrett’s with rapid expansion in the role of endoscopic eradication therapy (EET) for management of dysplastic and early neoplastic BE, and there have been substantial changes to international consensus guidelines for management of early BE based on evolving evidence. This review aims to assist the physician in the therapeutic decision-making process with patients by comprehensive review and summary of literature surrounding natural history of Barrett’s by histological stage, and the effectiveness of interventions in attenuating the risk posed by its natural history. Key findings were as follows. Non-dysplastic Barrett’s is associated with extremely low risk of progression, and interventions cannot be justified. The annual risk of cancer progression in low grade dysplasia is between 1%-3%; EET can be offered though evidence for its benefit remains confined to highly select settings. High-grade dysplasia progresses to cancer in 5%-10% per year; EET is similarly effective to and less morbid than surgery and should be routinely performed for this indication. Risk of nodal metastases in intramucosal cancer is 2%-4%, which is comparable to operative mortality rate, so EET is usually preferred. Submucosal cancer is associated with nodal metastases in 14%-41% hence surgery remains standard of care, except for select situations. 相似文献
4.
Josupeit Jan Dadaczynski Kevin Quilling Eike 《Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz》2022,65(7-8):829-835
Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz - Die Schule ist einer der wichtigsten Orte, an dem die Förderung der Gesundheit von Kindern und Jugendlichen ansetzen kann,... 相似文献
5.
6.
Willy Baccaglini Felipe A. Glina Cristiano Linck Pazeto Luis G. Medina Fernando Korkes Wanderley M. Bernardo Rene Sotelo Sidney Glina Giancarlo Marra Marco Moschini Xavier Cathelineau Rafael Sanchez-Salas 《Clinical genitourinary cancer》2021,19(1):3-11.e1
This meta-analysis focuses on the accuracy of upgrading to clinically significant prostate cancer (PCa) by multiparametric magnetic resonance imaging-targeted biopsy (MRI-TB) versus systematic biopsy (SB). We searched the Medline, Embase, Cochrane Central Register of Controlled Trials, Web of Science, Scopus, and Literatura Latino Americana em Ciências da Saúde databases through January 2020 for comparative, retrospective/prospective, paired-cohort, and randomized clinical trials with paired comparisons. The population consisted of patients with low-risk PCa in active surveillance with at least 1 index lesion on imaging. We evaluated the quality of evidence by using the Quality Assessment of Diagnostic Accuracy Studies-2 score. Group comparisons considered the differences between the area under the curve summary receiver operating characteristic curve in a 2-tailed method. We also compared the positive predictive value of the best single method (MRI-TB or SB) and the referral study test (combined biopsy, a combination of MRI-TB and SB). The meta-analysis included 6 studies enrolling 741 patients. The pooled sensitivity for the 2 groups was 0.79 (95% confidence interval, 0.74-0.83; I2 = 75%) and 0.67 (95% confidence interval, 0.63-0.74; I2 = 55.4%), respectively. The area under the curve for the MRI-TB and SB groups were 0.99 and 0.92 (P < .001), respectively. The positive predictive value for the MRI-TB and combined biopsy groups were similar. The accumulated evidence suggests better results for MRI-TB compared with SB. Therefore, use of MRI-TB alone may be preferable in patients in active surveillance harboring low-risk PCa. 相似文献
7.
8.
9.